24-hour Control of Intraocular Pressure (IOP) in Ocular Hypertension

NCT01655758 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Ocular Hypertension

Interventions

DRUG: 0.5% timolol
DRUG: timolol-dorzolamide fixed combination
DRUG: Latanoprost
DRUG: Travoprost
DRUG: Bimatoprost

Sponsor

University of Parma